A community engagement training program for basic and translational cancer researchers.

Cancer Community outreach and engagement Patient research advocate Training program

Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 01 01 2023
accepted: 04 07 2023
medline: 5 10 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: ppublish

Résumé

There is an increasing awareness of the importance of patient engagement in cancer research, but many basic and translational researchers have never been trained to do so. To address this unmet need, a 1-year patient engagement training program for researchers was developed. Eleven researchers and eleven paired research advocates participated. This program, designed for virtual delivery, included 3 didactic modules focused on (1) Community Outreach and Engagement principles and methods, (2) Communication skills, and (3) Team Science. This was followed by longitudinal projects to be completed by the researcher/advocate pairs, including learning about the research project, and co-authoring abstracts, manuscripts and grant proposals. Monthly group meetings allowed pairs to share their experiences. The program culminated in the pairs creating and presenting oral abstracts for the University of Kansas Cancer Center's Annual Research Symposium. All participants indicated that the modules had a positive impact on their ability to collaborate in research. Both researcher self-evaluations and patient advocate evaluations of their researcher partner showed an improvement in researcher communication competency. Results from the Patient Engagement in Research Scale showed that advocates were highly engaged. Within 1 year after program completion, participating pairs have completed four abstracts and 9 grant proposals. The program will be modified based on participant feedback, and can be adapted for future cohorts if an increased number of sessions per month and shortened program duration are desired. The program's virtual format allows scalability across institutions to potentially benefit large cohorts of researchers.

Identifiants

pubmed: 37505316
doi: 10.1007/s10552-023-01752-5
pii: 10.1007/s10552-023-01752-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1132

Subventions

Organisme : NIH HHS
ID : P30CA168524-09S4
Pays : United States
Organisme : NIH HHS
ID : P30CA168524-09S4
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Ciccarella A, Staley AC, Franco AT (2018) Transforming research: engaging patient advocates at all stages of cancer research. Ann Transl Med 6:167
doi: 10.21037/atm.2018.04.46 pubmed: 29911115 pmcid: 5985270
Salamone JM, Lucas W, Brundage SB et al (2018) Promoting scientist-advocate collaborations in cancer research: why and how. Cancer Res 78:5723–5728
doi: 10.1158/0008-5472.CAN-18-1600 pubmed: 30120210 pmcid: 6548189
Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW (2020) Clinical trials-designing, implementing, and collaborating. J Surg Oncol 122:25–28
doi: 10.1002/jso.25889 pubmed: 32149390 pmcid: 7598771
National Academies of Sciences E, and Medicine (2017) Communicating science effectively: a research agenda. Washington, DC: The National Academies Press. https://doi.org/10.17226/23674
Kaplan-Liss E, Lantz-Gefroh V, Bass E et al (2018) Teaching medical students to communicate with empathy and clarity using improvisation. Acad Med 93:440–443
doi: 10.1097/ACM.0000000000002031 pubmed: 29059072
Clifton D (2017) Discover your CliftonStrengths. Gallup Press, New York
Tuckman BW (1965) Developmental sequence in small groups. Psychol Bull 63:384–399
doi: 10.1037/h0022100 pubmed: 14314073
Hamilton CB, Hoens AM, McQuitty S et al (2018) Development and pre-testing of the patient engagement in research scale (PEIRS) to assess the quality of engagement from a patient perspective. PLoS ONE 13:e0206588
doi: 10.1371/journal.pone.0206588 pubmed: 30383823 pmcid: 6211727

Auteurs

Ronald C Chen (RC)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. Rchen2@kumc.edu.
Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA. Rchen2@kumc.edu.

Hope Krebill (H)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Masonic Cancer Alliance, University of Kansas Medical Center, Fairway, KS, USA.

Teri Kennedy (T)

Office of Interprofessional Practice, Education, Policy, & Research, University of Kansas School of Nursing, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Population Health, University of Kansas School of Medicine, Kansas City, KS, USA.

Sara Douglas (S)

Patient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.

Kristi L Neufeld (KL)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.

Danny R Welch (DR)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.

Cheryl Jernigan (C)

Patient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.

Kim S Kimminau (KS)

Patient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.
University of Missouri School of Medicine, Columbia, MO, USA.

Kristy Johnston (K)

Center for Interprofessional Practice, Education, and Research , University of Kansas Medical Center, Kansas City, KS, USA.

Jane Hughes (J)

Organizational Development Office, University of Kansas Medical Center, Kansas City, KS, USA.

Roy A Jensen (RA)

University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH